ATE349447T1 - Alkylamino-substituierte bicyclische heterocyclen als p38 protein kinase inhibitoren - Google Patents
Alkylamino-substituierte bicyclische heterocyclen als p38 protein kinase inhibitorenInfo
- Publication number
- ATE349447T1 ATE349447T1 AT00972755T AT00972755T ATE349447T1 AT E349447 T1 ATE349447 T1 AT E349447T1 AT 00972755 T AT00972755 T AT 00972755T AT 00972755 T AT00972755 T AT 00972755T AT E349447 T1 ATE349447 T1 AT E349447T1
- Authority
- AT
- Austria
- Prior art keywords
- alkylamino
- protein kinase
- kinase inhibitors
- substituted bicyclic
- bicyclic heterocycles
- Prior art date
Links
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title 1
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16080499P | 1999-10-21 | 1999-10-21 | |
| US21371800P | 2000-06-22 | 2000-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE349447T1 true ATE349447T1 (de) | 2007-01-15 |
Family
ID=26857242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00972755T ATE349447T1 (de) | 1999-10-21 | 2000-10-13 | Alkylamino-substituierte bicyclische heterocyclen als p38 protein kinase inhibitoren |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6642241B1 (de) |
| EP (1) | EP1226144B1 (de) |
| KR (1) | KR100537241B1 (de) |
| CN (1) | CN1156477C (de) |
| AR (1) | AR026187A1 (de) |
| AT (1) | ATE349447T1 (de) |
| AU (1) | AU776695B2 (de) |
| BR (1) | BR0014973A (de) |
| CA (1) | CA2388140C (de) |
| CO (1) | CO5251408A1 (de) |
| CZ (1) | CZ20021743A3 (de) |
| DE (1) | DE60032623T2 (de) |
| ES (1) | ES2277858T3 (de) |
| HR (1) | HRP20020327A2 (de) |
| HU (1) | HUP0203477A3 (de) |
| IL (1) | IL149230A0 (de) |
| MA (1) | MA26836A1 (de) |
| MX (1) | MXPA02003841A (de) |
| NO (1) | NO20021783L (de) |
| PE (1) | PE20010760A1 (de) |
| PL (1) | PL357494A1 (de) |
| TR (1) | TR200201058T2 (de) |
| WO (1) | WO2001029041A1 (de) |
| YU (1) | YU29202A (de) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU73300A (sh) | 1998-05-26 | 2003-08-29 | Warner-Lambert Company | Biciklični pirimidini i biciklični 3,4-dihidropirimidini kao inhibitori ćelijske proliferacije |
| US20040044012A1 (en) * | 1998-05-26 | 2004-03-04 | Dobrusin Ellen Myra | Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| RU2004133811A (ru) * | 2002-04-19 | 2005-04-20 | Смитклайн Бичам Корпорейшн (US) | Новые соединения |
| EP1534282B1 (de) | 2002-07-09 | 2006-12-27 | Boehringer Ingelheim Pharma GmbH & Co.KG | Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
| PA8577501A1 (es) | 2002-07-25 | 2004-02-07 | Warner Lambert Co | Inhibidores de quinasas |
| ATE374201T1 (de) * | 2002-08-06 | 2007-10-15 | Hoffmann La Roche | 6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase |
| KR100793688B1 (ko) * | 2002-08-06 | 2008-01-10 | 에프. 호프만-라 로슈 아게 | Ｐ-38 미토겐 활성 단백질 키나제 억제제로서6-알콕시-피리도-피리미딘 |
| US7084270B2 (en) * | 2002-08-14 | 2006-08-01 | Hoffman-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
| TW200413381A (en) * | 2002-11-04 | 2004-08-01 | Hoffmann La Roche | Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
| US7129351B2 (en) | 2002-11-04 | 2006-10-31 | Hoffmann-La Roche Inc. | Pyrimido compounds having antiproliferative activity |
| JP2006522756A (ja) * | 2003-04-10 | 2006-10-05 | エフ．ホフマン−ラ ロシュ アーゲー | ピリミド化合物 |
| US20080131370A1 (en) * | 2004-04-27 | 2008-06-05 | Takeda Pharmaceutical Company Limited | Screening Method |
| US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| CN1980933B (zh) | 2004-08-31 | 2010-07-14 | 霍夫曼-拉罗奇有限公司 | 3-苯基-二氢嘧啶并[4,5-d]嘧啶酮的酰胺衍生物，它们的制备和用作药剂的用途 |
| CN1984914A (zh) | 2004-08-31 | 2007-06-20 | 霍夫曼-拉罗奇有限公司 | 7－氨基－3－苯基－二氢嘧啶并[4,5－d]嘧啶酮的酰胺衍生物、其制备和作为蛋白激酶抑制剂的应用 |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| JP2009525292A (ja) | 2006-01-31 | 2009-07-09 | エフ．ホフマン−ラ ロシュ アーゲー | ７ｈ−ピリド［３，４−ｄ］ピリミジン−８−オン、それらの製造及びプロテインキナーゼ阻害剤としての使用 |
| EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
| EP2108641A1 (de) * | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | Neue substituierte Spiro[Cycloalkyl-1,3'-indo]-2'(1'H)-on-Derivate und ihre Verwendung als p38 mitogen-activated Kinase Inhibitoren |
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| ES2832497T3 (es) | 2012-06-13 | 2021-06-10 | Incyte Holdings Corp | Compuestos tricíclicos sustituidos como inhibidores de FGFR |
| US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| TWI647220B (zh) | 2013-03-15 | 2019-01-11 | 美商西建卡爾有限責任公司 | 雜芳基化合物及其用途 |
| EP3943087A1 (de) | 2013-03-15 | 2022-01-26 | Celgene CAR LLC | Heteroarylverbindungen und verwendungen davon |
| BR112015022191A8 (pt) | 2013-03-15 | 2018-01-23 | Celgene Avilomics Res Inc | compostos heteroarila e usos dos mesmos |
| SI2986610T1 (en) | 2013-04-19 | 2018-04-30 | Incyte Holdings Corporation | Bicyclic heterocycles as fgfr inhibitors |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| EA038045B1 (ru) | 2015-02-20 | 2021-06-28 | Инсайт Корпорейшн | Бициклические гетероциклы в качестве ингибиторов fgfr |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| CA3127373A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| BR112020022373A2 (pt) | 2018-05-04 | 2021-02-02 | Incyte Corporation | sais de um inibidor de fgfr |
| MA52494B1 (fr) | 2018-05-04 | 2024-10-31 | Incyte Corporation | Formes solides d'un inhibiteur de fgfr et leurs procédés de préparation |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| WO2021067374A1 (en) | 2019-10-01 | 2021-04-08 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| KR20220100879A (ko) | 2019-10-14 | 2022-07-18 | 인사이트 코포레이션 | Fgfr 저해제로서의 이환식 헤테로사이클 |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| GB201915828D0 (en) * | 2019-10-31 | 2019-12-18 | Cancer Research Tech Ltd | Compounds, compositions and therapeutic uses thereof |
| US11407750B2 (en) | 2019-12-04 | 2022-08-09 | Incyte Corporation | Derivatives of an FGFR inhibitor |
| EP4069696A1 (de) | 2019-12-04 | 2022-10-12 | Incyte Corporation | Tricyclische heterocyclen als fgfr-inhibitoren |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| US12065494B2 (en) | 2021-04-12 | 2024-08-20 | Incyte Corporation | Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent |
| WO2022261160A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814352D0 (en) | 1988-06-16 | 1988-07-20 | Smith Kline French Lab | Chemical compounds |
| IL117923A (en) | 1995-05-03 | 2000-06-01 | Warner Lambert Co | Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds |
| US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
| ES2221213T3 (es) * | 1997-10-20 | 2004-12-16 | F. Hoffmann-La Roche Ag | Inhibidores de kinasa biciclicos. |
| YU73300A (sh) * | 1998-05-26 | 2003-08-29 | Warner-Lambert Company | Biciklični pirimidini i biciklični 3,4-dihidropirimidini kao inhibitori ćelijske proliferacije |
| ID28276A (id) | 1998-10-23 | 2001-05-10 | Hoffmann La Roche | Heterolingkar nitrogen bisiklik |
-
2000
- 2000-10-13 DE DE60032623T patent/DE60032623T2/de not_active Expired - Fee Related
- 2000-10-13 CZ CZ20021743A patent/CZ20021743A3/cs unknown
- 2000-10-13 HU HU0203477A patent/HUP0203477A3/hu unknown
- 2000-10-13 CN CNB00814544XA patent/CN1156477C/zh not_active Expired - Fee Related
- 2000-10-13 AT AT00972755T patent/ATE349447T1/de not_active IP Right Cessation
- 2000-10-13 MX MXPA02003841A patent/MXPA02003841A/es active IP Right Grant
- 2000-10-13 BR BR0014973-0A patent/BR0014973A/pt not_active IP Right Cessation
- 2000-10-13 PL PL00357494A patent/PL357494A1/xx not_active Application Discontinuation
- 2000-10-13 ES ES00972755T patent/ES2277858T3/es not_active Expired - Lifetime
- 2000-10-13 HR HR20020327A patent/HRP20020327A2/hr not_active Application Discontinuation
- 2000-10-13 WO PCT/EP2000/010077 patent/WO2001029041A1/en not_active Application Discontinuation
- 2000-10-13 IL IL14923000A patent/IL149230A0/xx unknown
- 2000-10-13 TR TR2002/01058T patent/TR200201058T2/xx unknown
- 2000-10-13 CA CA002388140A patent/CA2388140C/en not_active Expired - Fee Related
- 2000-10-13 KR KR10-2002-7005056A patent/KR100537241B1/ko not_active Expired - Fee Related
- 2000-10-13 AU AU11375/01A patent/AU776695B2/en not_active Ceased
- 2000-10-13 EP EP00972755A patent/EP1226144B1/de not_active Expired - Lifetime
- 2000-10-13 YU YU29202A patent/YU29202A/sh unknown
- 2000-10-17 PE PE2000001106A patent/PE20010760A1/es not_active Application Discontinuation
- 2000-10-19 CO CO00079670A patent/CO5251408A1/es not_active Application Discontinuation
- 2000-10-20 US US09/693,364 patent/US6642241B1/en not_active Expired - Fee Related
- 2000-10-20 AR ARP000105524A patent/AR026187A1/es not_active Application Discontinuation
-
2002
- 2002-04-16 NO NO20021783A patent/NO20021783L/no not_active Application Discontinuation
- 2002-04-19 MA MA26611A patent/MA26836A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1137501A (en) | 2001-04-30 |
| CN1156477C (zh) | 2004-07-07 |
| CZ20021743A3 (cs) | 2002-08-14 |
| HRP20020327A2 (en) | 2004-02-29 |
| EP1226144B1 (de) | 2006-12-27 |
| NO20021783D0 (no) | 2002-04-16 |
| CO5251408A1 (es) | 2003-02-28 |
| IL149230A0 (en) | 2002-11-10 |
| HK1051040A1 (en) | 2003-07-18 |
| US6642241B1 (en) | 2003-11-04 |
| PL357494A1 (en) | 2004-07-26 |
| AR026187A1 (es) | 2003-01-29 |
| YU29202A (sh) | 2004-12-31 |
| CA2388140A1 (en) | 2001-04-26 |
| BR0014973A (pt) | 2002-07-16 |
| MXPA02003841A (es) | 2002-09-30 |
| NO20021783L (no) | 2002-04-16 |
| DE60032623T2 (de) | 2007-10-11 |
| JP4028236B2 (ja) | 2007-12-26 |
| CA2388140C (en) | 2008-09-02 |
| ES2277858T3 (es) | 2007-08-01 |
| WO2001029041A1 (en) | 2001-04-26 |
| KR20020039375A (ko) | 2002-05-25 |
| MA26836A1 (fr) | 2004-12-20 |
| AU776695B2 (en) | 2004-09-16 |
| DE60032623D1 (de) | 2007-02-08 |
| TR200201058T2 (tr) | 2002-07-22 |
| CN1382142A (zh) | 2002-11-27 |
| JP2003512377A (ja) | 2003-04-02 |
| HUP0203477A3 (en) | 2004-12-28 |
| PE20010760A1 (es) | 2001-07-21 |
| EP1226144A1 (de) | 2002-07-31 |
| HUP0203477A2 (hu) | 2003-01-28 |
| KR100537241B1 (ko) | 2005-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE349447T1 (de) | Alkylamino-substituierte bicyclische heterocyclen als p38 protein kinase inhibitoren | |
| DE69720522D1 (de) | Substituierte stickstoff enthaltende heterocyclen als p38 protein kinase inhibitoren | |
| ATE270670T1 (de) | Bicyclische heteroaromatische verbindungen als protein tyrosine kinase inhibitoren | |
| NO20021781D0 (no) | Heteroalkylamino-substituerte bicykliske nitrogenheterocykler som inhibitorer for P38-proteinkinase | |
| DE60128709D1 (de) | Triazol-verbindungen als protein-kinase-inhibitoren | |
| DE60119776D1 (de) | Pyrazolverbindungen als protein-kinase-inhibitoren | |
| DE69724789D1 (de) | Bicyclische heteroaromatic verbindungen als protein tyrosin kinase inhibitoren | |
| ATE430149T1 (de) | Heterocyclen substituierte imidazopyrazine als protein- tyrosin-kinase-inhibitoren | |
| DE69718472D1 (de) | Bicyclische heteroaromatische verbindungen als protein tyrosine kinase inhibitoren | |
| ATE445613T1 (de) | Indolylmaleimidderivative als proteinkinase-c- inhibitoren | |
| LTPA2014028I1 (lt) | Pakeistieji 3-cianochinolinai kaip proteintirozinkinazės inhibitoriai | |
| ATE214381T1 (de) | Thiazole derivate als protein kinase c inhibitoren | |
| ZA200202540B (en) | Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |